Skip to main content
Clinical Trials/CTRI/2024/07/070785
CTRI/2024/07/070785
Not yet recruiting
Phase 3

Superior laryngeal nerve block inIrritable larynx syndrome – aRandomized controlled trial - NI

All India Institute of Medical Sciences, Raebareli0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
All India Institute of Medical Sciences, Raebareli
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
All India Institute of Medical Sciences, Raebareli

Eligibility Criteria

Inclusion Criteria

  • Patients with symptoms of Irritable larynx syndrome:
  • 1\. Chronic neurogenic cough
  • 2\. Chronic throat clearing
  • 3\. Globus sensation (lump in the throat)
  • 4\. Episodic laryngospasm
  • 5\. Dysphonia
  • 6\. Throat pain (muscle tension)
  • 7\. Odynophagia

Exclusion Criteria

  • 1\.Anatomical abnormality and disorders of larynx (laryngeal or
  • oropharyngeal malignancy, infections like tuberculosis, fungal)
  • 2\.Functional disorders of the larynx (vocal cord palsy).
  • 3\.Chronic alcoholics or smokers.
  • 4\.Stylalgia
  • 5\.Pregnant ladies
  • 6\.Patients with known psychiatric disorders
  • 7\.Patients with known bleeding disorders
  • 8\.Patients on any concurrent neuromodulator therapy
  • 9\.Post operative patients of voice disorders (post micro laryngeal surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials